Cost-effectiveness analysis of thoracic radiotherapy in non-operated clinical stage IIIA non-small cell lung cancer

被引:0
|
作者
Chien, C. R. [1 ,2 ]
Wang, P. H. [3 ]
机构
[1] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan
[2] Ctr Canc, Taichung, Taiwan
[3] China Med Univ Hosp, Dept Canc Ctr, Taichung, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3437
引用
收藏
页码:S807 / S808
页数:2
相关论文
共 50 条
  • [1] The role of surgery in stage IIIA non-small cell lung cancer: a decision and cost-effectiveness analysis
    Samson, Pamela P.
    Patel, Aalok
    Robinson, Clifford G.
    Morgensztern, Daniel
    Chang, Su-Hsin
    Colditz, Graham A.
    Meyers, Bryan F.
    Crabtree, Traves D.
    Puri, Varun
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E142 - E143
  • [2] The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis
    Samson, Pamela
    Patel, Aalok
    Robinson, Cliff G.
    Morgensztern, Daniel
    Chang, Su-Hsin
    Colditz, Graham A.
    Waqar, Saiama
    Crabtree, Traves D.
    Krupnick, A. Sasha
    Kreisel, Daniel
    Patterson, G. Alexander
    Meyers, Bryan F.
    Puri, Varun
    ANNALS OF THORACIC SURGERY, 2015, 100 (06): : 2026 - 2032
  • [3] International Cost-Effectiveness Analysis of Durvalumab in Stage III Non-Small Cell Lung Cancer
    Kareff, Samuel A.
    Han, Sunwoo
    Haaland, Benjamin
    Jani, Chinmay J.
    Kohli, Rhea
    Aguiar Jr, Pedro Nazareth
    Huang, Yiqing
    Soo, Ross A.
    Rodriguez-Perez, Angel
    Garcia-Foncillas, Jesus
    Domine, Manuel
    de Lima Lopes, Gilberto
    JAMA NETWORK OPEN, 2024, 7 (05) : E2413938
  • [4] Thoracic radiotherapy for stage IV non-small cell lung cancer
    Chien, CR
    Yang, CH
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 (01) : 110 - 110
  • [5] Cost-effectiveness of immune checkpoint inhibitors and radiotherapy in advanced non-small cell lung cancer
    Giuliani, Jacopo
    Fiorica, Francesco
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (08) : 2004 - 2006
  • [6] The prognosis of clinical stage IIIa non-small cell lung cancer in Taiwan
    Cheng, Ya-Fu
    Huang, Jing-Yang
    Lin, Ching-Hsiung
    Wang, Bing-Yen
    CANCER MEDICINE, 2023, 12 (16): : 17087 - 17097
  • [7] Thermal ablation versus stereotactic body radiotherapy for stage I non-small cell lung cancer: A cost-effectiveness analysis.
    Wu, Xiao
    Uhlig, Johannes
    Blasberg, Justin
    Gettinger, Scott N.
    Suh, Robert
    Solomon, Stephen Barnett
    Kim, Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer
    Witlox, W.
    Ramaekers, B.
    Lacas, B.
    Le Pechoux, C.
    Sun, A.
    Wang, S.
    Hu, C.
    Redman, M.
    van der Noort, V.
    Li, N.
    Guckenberger, M.
    van Tinteren, H.
    Hendriks, L.
    Groen, H.
    Joore, M.
    de Ruysscher, D.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S887 - S889
  • [9] Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer
    Witlox, Willem J. A.
    Ramaekers, Bram L. T.
    Lacas, Benjamin
    Le Pechoux, Cecile
    Sun, Alexander
    Wang, Si-Yu
    Hu, Chen
    Redman, Mary
    van der Noort, Vincent
    Li, Ning
    Guckenberger, Matthias
    van Tinteren, Harm
    Hendriks, Lizza E. L.
    Groen, Harry J. M.
    Joore, Manuela A.
    De Ruysscher, Dirk K. M.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : 95 - 101
  • [10] Treatment of stage IIIA non-small cell lung cancer
    Robinson, LA
    Wagner, H
    Ruckdeschel, JC
    CHEST, 2003, 123 (01) : 202S - 220S